Abstract
Bosentan (endothelin ETA/ETB antagonist), pinacidil (potassium channel opener) and nitroprusside (nitric oxide donor) were examined on isolated ring preparations of human intralobar pulmonary artery (3rd-5th generation, internal radius > or = 1 mm), rat main pulmonary artery (1st generation; internal radius > or = 1 mm) and rat intralobar pulmonary artery (3rd generation; internal radius 0.1-0.3 mm). The potency of endothelin-1 was the same in all three artery types. In human intralobar artery and rat main pulmonary artery, bosentan (3 and 10 microM) shifted the endothelin-1 concentration response curve to a higher concentration range (endothelin-1 concentration ratios, in human intralobar and rat main pulmonary artery, respectively: 3 microM bosentan, 4.5 and 8.1; 10 microM bosentan, 13.5 and 19.5), but caused no significant block of endothelin-1 in rat intralobar artery. The latter finding may be due to the reported presence of ETB receptors in rat intralobar arteries and the higher potency of bosentan on ETA than on ETB receptors. In contrast, the potencies of nitroprusside and pinacidil (relaxation of submaximal contractions to the thromboxane-mimetic, U46619) agreed on human and rat intralobar arteries but were 6 to 16-fol...Continue Reading
References
Jan 1, 1992·British Journal of Pharmacology·J C Wanstall, S R O'Donnell
Jul 9, 1992·The New England Journal of Medicine·S RichP S Levy
Nov 9, 1991·Lancet·J Pepke-ZabaJ Wallwork
Feb 6, 1990·European Journal of Pharmacology·J C Wanstall, S R O'Donnell
Aug 1, 1986·British Journal of Pharmacology·J A AngusK Satoh
Sep 1, 1987·The American Review of Respiratory Disease·T Higenbottam
Mar 1, 1982·Canadian Journal of Physiology and Pharmacology·T P Kenakin
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·S L ArcherE K Weir
Jun 1, 1993·British Journal of Pharmacology·A T Dinh-XuanT W Higenbottam
Jan 1, 1995·Annual Review of Physiology·J R FinemanM A Heymann
Oct 1, 1994·British Journal of Pharmacology·T FukurodaM Nishikibe
Sep 1, 1993·Journal of Applied Physiology·M OkaI F McMurtry
Nov 1, 1993·British Journal of Pharmacology·D W HayB J Undem
Feb 1, 1993·Circulation·D S CelermajerJ E Deanfield
Feb 1, 1995·Pulmonary Pharmacology·S R O'Donnell, C S Kay
Jan 1, 1995·Journal of Cardiovascular Pharmacology·K M McCulloch, M R MacLean
Jan 1, 1995·Journal of Cardiovascular Pharmacology·F D Russell, A P Davenport
Mar 1, 1996·Circulation Research·S L ArcherE K Weir
Dec 1, 1995·Journal of Applied Physiology·S J ChenS Oparil
Jun 1, 1996·General Pharmacology·J C Wanstall
Citations
May 19, 2005·European Journal of Pharmacology·Britt ElmedalUlf Simonsen
Oct 7, 1998·European Journal of Pharmacology·K Homer, J Wanstall
Apr 25, 2000·Clinical and Experimental Pharmacology & Physiology·J C WanstallB J Thomas
Jun 28, 2008·Journal of Applied Physiology·Keshore R BidaseeKaushik P Patel
Mar 27, 2015·Current Infectious Disease Reports·Ahmed Akhter, Adnan Said
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Amitabh Prakash, Caroline M Perry